| Polymers in transdermal drug delivery systems S Kandavilli, V Nair, R Panchagnula Pharmaceutical technology 26 (5), 62-81, 2002 | 277 | 2002 |
| Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats S Khandavilli, R Panchagnula Journal of Investigative Dermatology 127 (1), 154-162, 2007 | 221 | 2007 |
| Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport MVS Varma, K Sateesh, R Panchagnula Molecular pharmaceutics 2 (1), 12-21, 2005 | 186 | 2005 |
| Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research MVS Varma, S Khandavilli, Y Ashokraj, A Jain, A Dhanikula, A Sood, ... Current drug metabolism 5 (5), 375-388, 2004 | 127 | 2004 |
| Development and validation of RP-HPLC and ultraviolet spectrophotometric methods of analysis for the quantitative estimation of antiretroviral drugs in pharmaceutical dosage forms M Sarkar, S Khandavilli, R Panchagnula Journal of Chromatography B 830 (2), 349-354, 2006 | 118 | 2006 |
| Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies R Panchagnula, R Bokalial, P Sharma, S Khandavilli International journal of pharmaceutics 293 (1-2), 213-223, 2005 | 104 | 2005 |
| Simultaneous determination of lamivudine and stavudine in antiretroviral fixed dose combinations by first derivative spectrophotometry and high performance liquid chromatography N Kapoor, S Khandavilli, R Panchagnula Journal of pharmaceutical and biomedical analysis 41 (3), 761-765, 2006 | 87 | 2006 |
| Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel R Panchagnula, H Desu, A Jain, S Khandavilli Journal of pharmaceutical sciences 93 (9), 2177-2183, 2004 | 69 | 2004 |
| Simultaneous determination of lamivudine, stavudine and nevirapine in antiretroviral fixed dose combinations by high performance liquid chromatography N Kapoor, S Khandavilli, R Panchagnula Analytica Chimica Acta 570 (1), 41-45, 2006 | 65 | 2006 |
| Fixed dose combinations for tuberculosis: lessons learned from clinical, formulation and regulatory perspective R Panchagnula, S Agrawal, Y Ashokraj, M Varma, K Sateesh, V Bhardwaj, ... Methods Find Exp Clin Pharmacol 26 (9), 703-721, 2004 | 56 | 2004 |
| Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers DK Shah, S Khandavilli, R Panchagnula Methods Find Exp Clin Pharmacol 30 (7), 499-512, 2008 | 46 | 2008 |
| Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation R Panchagnula, H Desu, A Jain, S Khandavilli Il Farmaco 60 (11-12), 894-899, 2005 | 42 | 2005 |
| Topical retinoid compositions S Kandavilli, F Okumu, MM Bankar, SK Dolai US Patent 9,931,328, 2018 | 28 | 2018 |
| RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation R Panchagnula, P Sharma, S Khandavilli, MVS Varma Il Farmaco 59 (10), 839-842, 2004 | 19 | 2004 |
| Evaluation of a nonsteroidal topical cream in a guinea pig model of Malassezia furfur infection V Nalamothu, AL O'Leary, S Kandavilli, J Fraser, V Pandya Clinics in dermatology 27 (6), S41-S43, 2009 | 17 | 2009 |
| Rational vehicle design ensures targeted cutaneous steroid delivery L Kircik, F Okumu, S Kandavilli, J Sugarman The Journal of Clinical and Aesthetic Dermatology 10 (2), 12, 2017 | 13 | 2017 |
| Topical compositions comprising 5-alpha reductase inhibitors S Kandavilli, V Nalamothu, V Pandya US Patent App. 12/544,737, 2010 | 12 | 2010 |
| Topical formulations comprising a steroid U Ubaidulla, S Kandavilli, AS Vairale, JA Wayne, V Nalamothu, M Meghal, ... US Patent 9,364,485, 2016 | 11 | 2016 |
| TOPICAL CORTICOSTEROID COMPOSITIONS S KANDAVALLI, P SAHUKAR, F OKUMU WO Patent WO/2015/138,650, 2015 | 8 | 2015 |
| Topical compositions comprising a corticosteroid S Kandavilli, M Bommagani, V Nalamothu, F Okumu US Patent 9,855,334, 2018 | 5 | 2018 |
Manthena V. VarmaPharmacokinetics, dynamics and metabolism在 pfizer.com 的电子邮件经过验证
